In an increasingly complex market for pharmaceutical drugs and medical devices, manufacturers are relying on electronic systems to produce, store, ship and track their products. In particular, extensive barcode labeling systems are crucial for ensuring a reliable, accurate and traceable supply chain.
Training is a critical step in educating users and administrators on the capabilities and options available to them that can be employed to best meet the labeling requirements for the business. And, getting that training directly from the people who developed the solution offers a real advantage.
Last week, we discussed the importance of the FDA's UDI compliance and how they have applied to the medical device industry. Now we'll look at what comes next.
The disruptive force of “The Cloud” was front and center at Oracle’s Modern Supply Chain Experience conference last week in San Jose, California. During this event Oracle presented its path for the future for its supply chain applications and not surprisingly the cloud is at the center of their plans. Oracle asserted that the market for supply chain applications on the cloud would grow from $1.8 billion in 2013 to $4.4 billion in 2018, which is a very significant 19% CAGR.
I had the wonderful opportunity to be part of the Oracle Modern Supply Chain Experience last week, located in beautiful San Jose, California. Apart from escaping the brutal New England winter for a week, the event opened my eyes to the amount of energy and passion towards supply chain methodologies, technologies, and solutions.
At a time when auto manufacturers are working hard on new technology to improve auto safety — such as crash warning systems and automatic braking — they and their customers face a growing threat. Counterfeit auto components are still finding their way into the global supply chain, and the improved quality of these parts is making detection more difficult than ever.
The most substantial benefit in implementing an Enterprise Labeling Solution is the cost savings companies can achieve by not duplicating efforts across the globe. Using an Enterprise Labeling Solution allows a centralized approach with the ability to allow for localized autonomy as appropriate.
The medical device industry has grown rapidly in recent years, and may soon outpace pharmaceuticals. For this reason, the FDA is in the process of implementing UDI regulations to improve device safety.
Adopted in 2003, the Restriction of Hazardous Substances (RoHS) Directive has prohibited the use of six different hazardous substances in electronics manufacturing since it took effect in Europe in 2006.
Business users are the closest to the labeling process and are on the frontlines, interacting with customers and managing the business’ labeling requirements.
As businesses grow their global supply chains, they have to focus on maintaining efficiency in the face of increased complexity. This year, global politics will pose an additional challenge.
We're in the midsts of the U.S. Food and Drug Administration's rollout of the Unique Device Identification (UDI) system. Beginning in September 2014 and continuing through 2020, medical device manufacturers will be required to add UDI labels to their products. At the outset, only pacemakers and heart valves were affected by the FDA's rules, but last September any implantable life-sustaining device was added into the fold.
Manufacturing supply chains are changing. Once upon a time, these were largely linear creations, static in nature and generally located in one country. In today's global economy, supply chains are larger and more complex than ever, and face new challenges from rapidly growing consumer demand.
There is a wide range of different enterprise applications and data repositories that could be integrated with labeling. Ultimately, business systems simply reflect the data that needs to appear on the label.